Successful ligelizumab treatment of severe refractory solar urticaria
The Journal of Allergy and Clinical Immunology: In Practice · 2023
DOI: 10.1016/j.jaip.2023.01.052 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2023. Verfasst von Yoav Hershkovitz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Allergy and Clinical Immunology Unit, Department of Medicine, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem…. Hauptthemen laut MEDLINE: Urticaria, Solar, Urticaria. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Allergy and Clinical Immunology Unit, Department of Medicine, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
- Photodermatosis Service, Division of Dermatology, Rabin Medical Center, Petah-Tikva, Israel; Department of Dermatology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Allergy and Clinical Immunology Unit, Department of Medicine, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. Electronic address: yuvalt@hadassah.org.il.
Zitieren
APA
Hershkovitz, Y., Khanimov, I., Rubin, L., Dranitzki, Z., Talmon, A., Ribak, Y., Shamriz, O., Levi, A., & Tal, Y. (2023). Successful ligelizumab treatment of severe refractory solar urticaria. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2023.01.052
Vancouver
Hershkovitz Y, Khanimov I, Rubin L, Dranitzki Z, Talmon A, Ribak Y, et al. Successful ligelizumab treatment of severe refractory solar urticaria. The Journal of Allergy and Clinical Immunology: In Practice. 2023. doi:10.1016/j.jaip.2023.01.052
BibTeX
@article{Hershkovitz2023,
author = {Hershkovitz, Yoav and Khanimov, Israel and Rubin, Limor and Dranitzki, Zvika and Talmon, Aviv and Ribak, Yaarit and Shamriz, Oded and Levi, Asi and Tal, Yuval},
title = {Successful ligelizumab treatment of severe refractory solar urticaria},
journal = {The Journal of Allergy and Clinical Immunology: In Practice},
year = {2023},
doi = {10.1016/j.jaip.2023.01.052}
}
EUVIMED